Form 8-K - Current report:
SEC Accession No. 0001213900-20-006187
Filing Date
2020-03-13
Accepted
2020-03-13 06:04:44
Documents
6
Period of Report
2020-03-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea119503-8k_aytubioscience.htm 8-K 33470
2 FORM OF PRE-FUNDED PURCHASE WARRANT ea119503ex4-1_aytubio.htm EX-4.1 105699
3 FORM OF PLACEMENT AGENT'S WARRANTS ea119503ex4-2_aytubio.htm EX-4.2 104988
4 OPINION OF DORSEY & WHITNEY LLP ea119503ex5-1_aytubio.htm EX-5.1 15587
5 FORM OF SECURITIES PURCHASE AGREEMENT, DATED MARCH 10, 2020, BY AND BETWEEN THE ea119503ex10-1_aytubio.htm EX-10.1 207076
6 PRESS RELEASE DATED MARCH 10, 2020 ea119503ex99-1_aytubio.htm EX-99.1 13973
  Complete submission text file 0001213900-20-006187.txt   482117
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 20710592
SIC: 2834 Pharmaceutical Preparations